St. Francis, which is based in Alameda, Calif., manufactures the first U.S. government-approved "interspinous process device for treating lumbar spinal stenosis," Kyphon said Monday in a news release.
The deal calls for Kyphon to pay $525 million in upfront cash payable upon closing, plus additional revenue-based contingent payments of up to $200 million payable in either cash or a combination of cash and stock, at Kyphon's election.
Kyphon will finance the upfront payment due upon closing through a combination of cash on hand and bank financing, including a syndicated term loan and credit facility.
Beyonce flaunts bikini body, Blue Ivy in vacation pics
Kate Middleton recycles dress at movie premiere